Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...
Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ...
The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics License Application (BLA ...
Novavax Inc (NVAX) outlines its strategic focus on partnerships and pipeline expansion while navigating revenue fluctuations ...
Organogenesis ( ORGO -5.54%) Q4 2024 Earnings Call Feb 27, 2025, 5:00 p.m. ET ...
The Intellectual Property Office of the Philippines (IPOPHL) said it expects a continued reduction in the resolution time of ...
Cash and cash equivalents of $131.9M as of December 31, 2024Cash runway extends through anticipated topline data readouts of COAST (early 2Q ...
Shoals Technologies Group, Inc. is a leader in solar EBOS, poised for growth with innovation, strong financials, and market ...
RedChip Companies will air interviews with Calidi Biotherapeutics, Inc. (NYSE American:CLDI) and OS Therapies Inc. (NYSE American:OSTX) on the RedChip Small Stocks, Big Money™ show, a sponsored ...
Operator: Good morning and welcome to Scholar Rock’s Fourth Quarter Financial Results and Business Update Call. All participants will be in listen-only mode. After the company’s […] ...
Transitioned lead commercial responsibility of Nuvaxovid COVID-19 vaccine to Sanofi beginning with the 2025-2026 season Achieved total revenue of $88 million in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback